Eman A Sobh

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Molecular Docking

Klebsiella Pneumoniae

Tyrosine Kinase

Early Breast Cancer

Top Venues

Drug development research

Future medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Eman A Sobh, Mohammed A Dahab, Eslam B Elkaeed, Aisha A Alsfouk, Ibrahim M Ibrahim, Ahmed M Metwaly, Ibrahim H Eissa
Discovery of new thieno[2,3- d ]pyrimidines as EGFR tyrosine kinase inhibitors for cancer treatment. Future medicinal chemistry (2023)
Khaled M H Hilmy, Fawzya N M Kishk, Esmat B A Shahen, Eman A Sobh, Mohamed A Hawata
New pyrrole derivatives as DNA gyrase and 14α-demethylase inhibitors: Design, synthesis, antimicrobial evaluation, and molecular docking. Drug development research (2023)
Eman A Sobh, Nadia A Khalil, Samar I Faggal, Marwa S A Hassan
New benzothienopyrimidine derivatives as dual EGFR/ARO inhibitors: Design, synthesis, and their cytotoxic effect on MCF-7 breast cancer cell line. Drug development research 83 (5) (2022)